Show simple item record

dc.contributor.authorMahon, M
dc.contributor.authorCody, D
dc.date.accessioned2019-07-08T13:43:46Z
dc.date.available2019-07-08T13:43:46Z
dc.date.issued2019-05
dc.identifier.urihttp://hdl.handle.net/10147/624756
dc.descriptionA 14 year old female was referred to Endocrinology out-patient department for assessment of short stature. A karyotype confirmed 45X karyotype consistent with Turner syndrome. On examination, the patient had a weight of 68.8 kg (>80th centile), height of 138.6 cm (<5th centile) with a body mass index (BMI) of 35.8 (>95th percentile). Ultrasound of abdomen and pelvis demonstrated pre-pubertal uterus and small ovaries. Raised pituitary gonadotrophins with LH of 14.6 IU/l and FSH of 111 were consistent with a primary gonadal failure picture. The decision was made to commence her on growth hormone (GH) therapy for treatment of her short stature secondary to Turner Syndrome. Initially she was started on 1.0 mg for two weeks then increased to 1.8 mg as per dosing schedule.en_US
dc.language.isoenen_US
dc.publisherIrish Medical Journalen_US
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/us/*
dc.subjectENDOCRINOLOGYen_US
dc.subjectGROWTH HORMONE THERAPYen_US
dc.subjectCHILD HEALTHen_US
dc.titleBenign Intracranial Hypertension Necessitating Ventriculoperitoneal Shunt Insertion Secondary to Growth Hormone Therapyen_US
dc.typeArticleen_US
dc.identifier.journalIrish Medical Journalen_US
refterms.dateFOA2019-07-08T13:43:47Z


Files in this item

Thumbnail
Name:
art7.html
Size:
29.14Kb
Format:
HTML
Description:
Main Article

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 United States
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 United States